Your browser doesn't support javascript.
loading
The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations.
Kubistova, Z; Mrazek, F; Lympany, P A; Lagan, A L; Arakelyan, A; Kriegova, E; Welsh, K I; Kolek, V; Zatloukal, J; Hutyrova, B; du Bois, R M; Petrek, M.
Affiliation
  • Kubistova Z; Immunology and Respiratory Medicine, Palacky University, Olomouc, Czech Republic.
Tissue Antigens ; 72(5): 483-6, 2008 Nov.
Article in En | MEDLINE | ID: mdl-18937792
ABSTRACT
Idiopathic pulmonary fibrosis (IPF), a severe lung disease with unknown aetiology, is thought to have an important genetic component. Single nucleotide polymorphism, C5507G, of the complement receptor 1 (CR1) gene, which affects the number of CR1 molecules on erythrocytes, has been associated with susceptibility to IPF in a single European population. To replicate this finding, 53 Czech IPF patients with 203 Czech healthy control subjects and 70 English IPF patients with 149 English controls were investigated. In both populations, there were no significant differences in distribution of CR1 C5507G variants between IPF patients and their appropriate control groups. In conclusion, the association of the CR1 C5507G polymorphism with susceptibility to IPF was not reproducible in Czech and English populations.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Pulmonary Fibrosis / Receptors, Complement 3b Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2008 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pulmonary Fibrosis / Receptors, Complement 3b Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2008 Type: Article